clofibrate has been researched along with nicotinyl alcohol in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (93.33) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballantyne, D; Carlson, LA; Olsson, G | 1 |
Schwartzkopff, W; Zschiedrich, M | 1 |
Augustin, J; Greten, H; Haase, W; Klose, G; Middelhoff, G; Mordasini, R; Müller, A | 1 |
Fodor, GP | 1 |
Wollenweber, J | 1 |
Keller, C; Wolfram, G; Zöllner, N | 1 |
Graham, L; Hickey, N; Mulcahy, R | 1 |
Reuter, W | 1 |
Maisenbacher, HJ; Mann, S | 1 |
Breuer, J; Leopold, G; Simane, Z; Stoll, KD | 1 |
Keller, C; Kilani, S; Wolfram, G; Zöllner, N | 1 |
Jacobsson, L; Lundholm, L | 1 |
Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 1 |
Momonaga, M; Tomozawa, H; Uemura, T; Yazawa, H | 1 |
6 trial(s) available for clofibrate and nicotinyl alcohol
Article | Year |
---|---|
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Topics: Cholestanol; Chylomicrons; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperlipidemias; Inositol; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Nicotinyl Alcohol; Triglycerides | 1978 |
[Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Drug Combinations; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Nicotinyl Alcohol; Pyridines; Triglycerides | 1978 |
Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
Topics: Analysis of Variance; Cholesterol; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Male; Middle Aged; Nicotinyl Alcohol; Placebos; Pyridines; Triglycerides | 1977 |
[Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Drug Combinations; Drug Therapy, Combination; Humans; Hyperlipidemias; Lipoproteins; Nicotinyl Alcohol; Placebos; Pyridines; Triglycerides | 1975 |
[Comparative clinico-pharmacological studies on the lipid lowering effect of EMO 100 and clofibrate].
Topics: Adult; Animals; Cholesterol; Clofibrate; Depression, Chemical; Drug Synergism; Humans; Hypolipidemic Agents; Male; Nicotinyl Alcohol; Pyridines; Rats; Triglycerides | 1975 |
[Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
Topics: Cholesterol; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Nicotinyl Alcohol; Placebos; Pyridines; Triglycerides | 1976 |
9 other study(ies) available for clofibrate and nicotinyl alcohol
Article | Year |
---|---|
On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Topics: Cholesterol; Clofibrate; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Nicotinyl Alcohol; Phospholipids; Triglycerides | 1977 |
[Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
Topics: Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Male; Middle Aged; Nicotinyl Alcohol; Pyridines | 1978 |
[The treatment of hypertriglyceridemia].
Topics: Clofibrate; Drug Combinations; Female; Humans; Hyperlipidemias; Male; Nicotinyl Alcohol; Pyridines; Triglycerides | 1978 |
[Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Topics: Angina Pectoris; Cerebrovascular Disorders; Cholesterol; Clofibrate; Delayed-Action Preparations; Follow-Up Studies; Humans; Hypercholesterolemia; Intermittent Claudication; Long-Term Care; Nicotinyl Alcohol; Pyridines; Triglycerides | 1976 |
[Effects of various modes of therapy on the fatty acid spectrum in hyperlipoproteinemia].
Topics: Cholesterol; Clofibrate; Fatty Acids; Humans; Hyperlipidemias; Nicotinyl Alcohol; Triglycerides; Xanthinol Niacinate | 1977 |
[Drug review. Liapten].
Topics: Clofibrate; Drug Combinations; Nicotinyl Alcohol; Pyridines | 1975 |
Experimental atherosclerosis in hypercholesterolemic mini-pigs. Regression of cholesterol ester accumulation in aorta and coronary arteries after treatment with clofibrate, beta-pyridylcarbinol or a normo-lipidemic diet.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol Esters; Cholesterol, Dietary; Clofibrate; Coronary Vessels; Dietary Fats; Female; Hypercholesterolemia; Lipids; Nicotinyl Alcohol; Swine; Swine, Miniature; Triglycerides | 1982 |
Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Topics: Adolescent; Bezafibrate; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Inositol; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nicotinic Acids; Nicotinyl Alcohol; Xanthinol Niacinate | 1980 |
Influence of powder characteristics of bulk substance with pharmaceutical processing.
Topics: Caprylates; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Clofibrate; Crystallization; Disulfides; Drug Combinations; Nicotinic Acids; Nicotinyl Alcohol; Pemoline; Powders; Pyrimidines; Solubility; Tensile Strength; Vitamins | 1998 |